期刊文献+

自闭性回肠插管造口预防直肠癌新辅助放化疗后低位前切除患者吻合口漏 被引量:12

Self close intubation ileostomy in the prevention of anastomotic leakage of anterior resection after neoadjuvant chemoradiation in patients of low rectal carcinoma
原文传递
导出
摘要 目的 探讨自闭性回肠插管造口在低位直肠癌新辅助放化疗后保肛手术预防吻合口漏的安全性和可行性.方法 收集2010-2013年浙江省德清县人民医院和浙江大学附属第一医院肛肠外科收治的54例中低位直肠癌新辅助放化疗后保肛手术患者的临床资料.54例随机分为两组,A组为自闭性回肠插管造口术28例,B组为传统回肠襻式造口术26例,观察两组患者术后并发症、安全性和经济、社会性等方面的意义.结果 两组回肠造口方式均对直肠吻合口有保护作用,其中A组保护时间平均为21(15 ~35)d,造口导管拔除后造口自动闭合(愈合)的成功率为100%;B组患者术后3~6个月再次行造口回纳术,术后出现严重并发症1例.两组术后均未出现明显的吻合口漏.结论 在中低位直肠癌新辅助放化疗后自闭性回肠插管造口术能够起到和传统回肠造口术相同的预防吻合漏的作用,且安全性高,医疗费用低,能有效避免再次造口回纳术给患者带来的创伤和经济负担. Objective To explore the safety and applicability of a temporary protective ileostomy that closes itself in the prevention of anastomotic leakage following anterior resection after chemoradiation for rectal cancer.Methods From Oct 2010 to Oct 2013,54 cases of middle or low rectal carcinoma were admitted.Protective ileostomy was created to prevent anastomotic leakage.Patients were divided into two groups receiving respectively intubation ileostomy (group A,28 cases),and conventional ileostomy (group B,26 cases).Results The mean time for anus to restore defecation was identical in the two groups.The period of protection of the anastomosis,was 21 d (15 ~ 35 d) in group A.The rate of spontaneous closure of the stoma after removal of the tube was 100%.The stoma was reduced after 3 to 6 months in group B and major complication developed in one case in this group.Conclusions Temporary ileostomy prevents anastomotic leakage of anterior resection in patients of rectal carcinoma receiving preoperative neoadjuvant chemoradiotherapy.Intubation ileostomy is effective and safe in prevention of anastomotic leakage saving stoma reduction procedures.
出处 《中华普通外科杂志》 CSCD 北大核心 2014年第7期531-533,共3页 Chinese Journal of General Surgery
关键词 直肠肿瘤 回肠造口术 肿瘤辅助疗法 吻合口漏 Rectal neoplasms Ileostomy Anastomotic leakage Neoadjuvant therapy
  • 相关文献

参考文献5

二级参考文献35

  • 1G6rard .IP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:resuhs of FFCD 9203. J Clin Oncol, 2006,24(28) :4620-4625.
  • 2Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med, 2006,355(11 ) : 1114-1123.
  • 3Ceelen W, Fierens K, Nieuwenhove YV, et al. Preoperative chemoradiation versus radiation alone for stage Ⅱ and Ⅲ resectable rectal cancer: A systematic review and meta-analysis. Int J Cancer, 2009, 124 (12) : 2966-2972.
  • 4Sobin LH, Gospodarowicz MK, Wittekind C, et al. TNM classification of malignant tumors. 7th ed. Hoboken: John Wiley & Sons, 2009.
  • 5Carlomagno C, Farella A, Buccci L, et al. Neoadjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: a phase Ⅱ study. Ann Oncol, 2009,20(5) :906-912.
  • 6Grzebieniak Z, Szynglarewicz B. Anastomotic leakage following anterior resection for rectal carcinoma. Przegl Lek, 2006,63 (7) : 543-546.
  • 7Kerr SF, Norton S, Glynne-Jones R. Delaying surgery afterneoadjuvant chemoradiotherapy for rectal cancer may reduce postoperative morbidity without compromising prognosis. Br J Surg, 2008,95(12) : 1534-1540.
  • 8Widder J, Herbst F, Dobrowsky W, et al. Preoperative short- term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer(phase Ⅱ ). Br J Cancer, 2005,92:1209- 1214.
  • 9Habr-Gama A, Perez RO, Nadalin W, et at. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg, 2005,9 ( 1 ) : 90-101.
  • 10Valero G, Lujan JA, Hemandez Q, et al. Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Coloreetal Dis, 2003,18 (6): 500-502.

共引文献46

同被引文献113

  • 1顾晋.低位直肠癌的外科手术[J].肿瘤学杂志,2006,12(1):27-30. 被引量:54
  • 2Kiran RP, Kirat HT, Burgess AN, et al. Is adjuvant chemotherapyreally needed after curative surgery for rectal cancer patients whoare node-negative after neoadjuvant chemoradiotherapy. Ann SurgOncol, 2012,19(4):1206-1212.
  • 3Patel JA,Fleshman JW, Hunt SR, et al. Is an elective divertingcolostomy warranted in patients with an endoscopically obstructingrectal cancer before neoadjuvant chemotherapy. Dis Colon Rectum,2012,55(3):249-255.
  • 4曾智帆,万德森,丁培荣,等.直肠癌新辅助治疗后淋巴结转移相关因素分析//广东省大肠癌学术会议,2009:923-927.
  • 5曹暂剑,乔峰妮.结直肠癌新辅助化疗的相关问题分析//中国肛肠病研究心得集,2011:327-330.
  • 6Fouda E, Nakeeb EA, Magdy A, et al. Early detection of anastomotic leakage after elective low anterior resection [ J ]. J Gastrointest Surg, 2011,15 ( 1 ) : 137-144.
  • 7Kang CY, Halabi WJ, Chaudhry OO, et al. Risk Factors for Anastomot- ic Leakage After Anterior Resection for Rectal Cancer[ J ]. JAMA Sur- gery,2013,148 ( 1 ) :65-71.
  • 8Ricardi U, Racca P, Franco P, et al. Prospective phase II trial of neo- adjuvant ehemo-radiotherapy with Oxaliplatin and Capecitabine in lo- cally advanced rectal cancer (XELOXART) [ J ]. Medical oncology, 2013,30(2) :581-581.
  • 9Mimezami A, Mimezami R, Chandrakumaran K, et al. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak:systematic review and meta-analysis[ J]. Ann Surg, 2011,253 (5) : 890-899.
  • 10Abegg RM, Brokelman W, van Bebber IP,et al. Results of construc- tion of protective loop ileostomies and reversal surgery for colorectal surgery[ J]. Eur Surg Res ,2014,52 ( 1-2 ) :63-72.

引证文献12

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部